Status:
COMPLETED
Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet
Lead Sponsor:
Amorepacific Corporation
Conditions:
Blood Glucose, High
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The objective of this clinical trial is to evaluate the short term effects of single dose AP green tea extracts in subjects with BMI (\< 30 kg/m2) and fasting glucose level of \> 100 mg/dL after high-...
Eligibility Criteria
Inclusion
- Subjects aged 19 years or over
- BMI \< 30 kg/m2
- Fasting glucose level \> 100 mg/dL (who is not under medication)
- Subjects who voluntarily decide to participate in this clinical study and sign the informed consent form on their own or through their representatives
Exclusion
- At the screening visit, subjects who were diagnosed with obesity, diabetes, dyslipidemia and undergoing medication
- Subjects who were diagnosed with ventricular associated disease, unstable and uncontrolled chronic medical disease, hyper/hypothyroidism, or active malignant tumor and undergoing medication within 4 weeks prior to the first administration of the investigational product
- Subjects who have renal failure, acute or chronic hepatitis or known liver cirrhosis
- In addition to the above, subjects who are determined to be ineligible to participate in the clinical study according to the investigator's medical opinion
Key Trial Info
Start Date :
July 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 26 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04850326
Start Date
July 24 2020
End Date
February 26 2021
Last Update
June 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KangBuk Samsung Medical Center
Seoul, South Korea, 03181